研報掘金丨長江證券:美的集團持續強化全球業務佈局,維持“買入”評級
長江證券研報指出,美的集團(000333.SZ)2025Q1實現歸母淨利潤124.22億元,同比增長38.02%。C端與B端共振,公司營收實現快速增長。公司已建立ToC與ToB並重發展的業務矩陣,可提供多元化的產品種類與服務,保持科技領先地位,持續強化全球業務佈局,以實現業務規模的可持續增長;在此基礎上,公司推動全價值鏈的數字化運營,以實現效率優化。公司C端業務具備領先優勢,B端業務體現出較強勢能,持續強化經營效率,預計公司2025-2027年歸母淨利潤分別爲425.88、468.06和521.34億元,對應PE分別爲13.35、12.15和10.91倍,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.